Veloxity Director of Quality Assurance, Christopher Tudan, PhD., spoke about the differences between the recently adopted M10 Guidance compared to the past EMA and FDA Guidances on Bioanalytical Method Validation and Sample Analysis during the November 1 AAPS eChalk Talks, at 11:15am EDT.



Please complete the form below to receive a copy of the presentation